Niki Patel

944 total citations · 1 hit paper
22 papers, 504 citations indexed

About

Niki Patel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Niki Patel has authored 22 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Niki Patel's work include Advanced Breast Cancer Therapies (7 papers), HER2/EGFR in Cancer Research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Niki Patel is often cited by papers focused on Advanced Breast Cancer Therapies (7 papers), HER2/EGFR in Cancer Research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Niki Patel collaborates with scholars based in United States, Australia and Malaysia. Niki Patel's co-authors include Wolfgang Mayer, Farhad Ahamed, Markus Stumptner, Georg Großmann, Zohaib Jan, Timothy B. Sackton, M. Sugumaran, Sarah Mathews, Matteo Bassetti and Daniele Roberto Giacobbe and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Current Biology.

In The Last Decade

Niki Patel

20 papers receiving 490 citations

Hit Papers

Artificial intelligence for industry 4.0: Systematic revi... 2022 2026 2023 2024 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Artificial intelligence for industry 4.0: Systematic review of applications, challenges, and opportunities
    2022 272 citations Zohaib Jan, Farhad Ahamed et al. Expert Systems with Applications profile →

Peers

Niki Patel
Siyuan Fan China
Xuemei Huang China
Laura Belli Italy
Arthur Hsu Australia
Rui Mu China
Ajay Singh Yadav India
Yong Cao China
Yuhlong Lio United States
Haoqi Wang China
Siyuan Fan China
Niki Patel
Citations per year, relative to Niki Patel Niki Patel (= 1×) peers Siyuan Fan

Countries citing papers authored by Niki Patel

Since Specialization
Citations

This map shows the geographic impact of Niki Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niki Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niki Patel more than expected).

Fields of papers citing papers by Niki Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niki Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niki Patel. The network helps show where Niki Patel may publish in the future.

Co-authorship network of co-authors of Niki Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Niki Patel. A scholar is included among the top collaborators of Niki Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niki Patel. Niki Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Veronica, Linda D. Bosserman, Sayeh Lavasani, et al.. (2024). UGT1A1*28 polymorphism and the risk of toxicity and disease progression in patients with breast cancer receiving sacituzumab govitecan. Cancer Medicine. 13(16). e70096–e70096. 6 indexed citations
2.
Rainone, Michael, Carolyn E. Behrendt, Saro Kasparian, et al.. (2023). HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia. Breast Cancer. 30(5). 796–801. 3 indexed citations
3.
Behrendt, Carolyn E., Susan E. Yost, Niki Patel, et al.. (2023). Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer. The Oncologist. 28(7). e488–e492. 5 indexed citations
4.
Yuan, Yuan, Susan E. Yost, Yujie Cui, et al.. (2023). Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer. The Oncologist. 28(7). e498–e507. 9 indexed citations
5.
Rainone, Michael, Saro Kasparian, Tina Nguyen, et al.. (2023). Thrombopoietin Receptor Agonists for Thrombocytopenia Secondary to HER2-Targeted Antibody Drug Conjugates. The Oncologist. 28(9). e843–e846. 2 indexed citations
6.
Behrendt, Carolyn E., Linda D. Bosserman, Sayeh Lavasani, et al.. (2023). UGT1A1 *28/*28 genotype and risk of toxicity and disease progression in breast cancer patients treated with sacituzumab govitecan-hziy.. Journal of Clinical Oncology. 41(16_suppl). 1033–1033. 6 indexed citations
7.
Jan, Zohaib, Farhad Ahamed, Wolfgang Mayer, et al.. (2022). Artificial intelligence for industry 4.0: Systematic review of applications, challenges, and opportunities. Expert Systems with Applications. 216. 119456–119456. 272 indexed citations breakdown →
8.
Behrendt, Carolyn E., Susan E. Yost, Niki Patel, et al.. (2022). Predicting hyperglycemia among patients receiving alpelisib plus fulvestrant for metastatic breast cancer.. Journal of Clinical Oncology. 40(16_suppl). 1060–1060. 1 indexed citations
9.
Rainone, Michael, Carolyn E. Behrendt, Saro Kasparian, et al.. (2022). HER2-targeted immunoconjugates for breast cancer: Ancestry and dose adjustment for thrombocytopenia.. Journal of Clinical Oncology. 40(16_suppl). 1048–1048. 1 indexed citations
10.
Satriadi, Kadek Ananta, et al.. (2022). Augmented Scale Models: Presenting Multivariate Data Around Physical Scale Models in Augmented Reality. 54–63. 9 indexed citations
11.
Cai, Liming, Brian Arnold, Zhenxiang Xi, et al.. (2021). Deeply Altered Genome Architecture in the Endoparasitic Flowering Plant Sapria himalayana Griff. (Rafflesiaceae). Current Biology. 31(5). 1002–1011.e9. 79 indexed citations
12.
Yuan, Yuan, Jin Sun Lee, Susan E. Yost, et al.. (2021). Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer. European Journal of Cancer. 154. 11–20. 61 indexed citations
13.
Yuan, Yuan, Susan E. Yost, Paul Frankel, et al.. (2021). A phase I/IB study of ipatasertib in combination with carboplatin or carboplatin/paclitaxel or capecitabine and atezolizumab in patients with metastatic triple-negative breast cancer.. Journal of Clinical Oncology. 39(15_suppl). 1078–1078. 2 indexed citations
14.
Lee, Jin Sun, Susan E. Yost, Tracey Stiller, et al.. (2020). Tolerability of neratinib in older adults with HER2 positive or HER2 mutated metastatic breast cancer.. Journal of Clinical Oncology. 38(15_suppl). e13018–e13018. 1 indexed citations
15.
16.
Weiss, Eric A., Simran Randhawa, Solomon Praveen Samuel, et al.. (2018). The impact of enoxaparin administration in relationship to hemorrhage in mild traumatic brain injury. Injury. 49(12). 2174–2177. 1 indexed citations
17.
Cohn, Jason E., Michael Pfeiffer, Niki Patel, Robert T. Sataloff, & Brian J. McKinnon. (2017). Identifying eustachian tube dysfunction prior to hyperbaric oxygen therapy: Who is at risk for intolerance?. American Journal of Otolaryngology. 39(1). 14–19. 3 indexed citations
18.
19.
Patel, Niki, et al.. (2010). Adult Onset Still's Disease and Rocky Mountain Spotted Fever. Case Reports in Medicine. 2010. 1–4. 2 indexed citations
20.
Patel, Niki. (2010). Study of methods to predict voltage collapse.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siyuan Fan Breakdown of academic impact, for papers by Xuemei Huang Breakdown of academic impact, for papers by Laura Belli Breakdown of academic impact, for papers by Arthur Hsu Breakdown of academic impact, for papers by Rui Mu Breakdown of academic impact, for papers by Ajay Singh Yadav Breakdown of academic impact, for papers by Yong Cao Breakdown of academic impact, for papers by Yuhlong Lio Breakdown of academic impact, for papers by Haoqi Wang
Rankless by CCL
2026